The first time you try to get something approved by the FDA is more risky. If it is not a "new" drug or process or otherwise, you can run into possible patent and legal issues. If a company has received a CRL then the second time they try to get a drug approved there should be less risk involved than the first time.
Market Data 
Markets 
AI
